Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech […]
Read MoreSecond patient dies after getting Sarepta’s Duchenne gene therapy
Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.45. Sarepta Therapeutics said Sunday that it was halting shipments of its […]
Read MoreAs financial prospects for gene therapies dim, ambitious charity steps up
MILAN — For more than three decades, a charity here has funded research aimed at developing medicines for genetic diseases. Recently, though, it added an unusual new role — as […]
Read MoreOvercoming ‘irrational pessimism’ slowing gene, CRISPR therapies
NEW YORK — To gene therapy pioneer Jim Wilson, the field is currently clouded with “irrational pessimism.” Companies are abandoning ship; approved therapies aren’t being prescribed. Yet both he and […]
Read More